Bioheart, Inc (NASDAQ: BHRT) is an advanced technology partner for heart failure specialists and their patients.
Bioheart is building a leading position within the cardiovascular sector of cell technology, delivering cell therapies, intelligent devices and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarction and other conditions. Bioheart’s products aim to cause damaged tissue to be regenerated, if possible, and to improve a patient’s quality of life while reducing health care costs and hospitalizations. www.bioheartinc.com